Use of Ozempic is associated with a lower risk of cognitive impairment, researchers found in a new study. But the findings don’t apply to users without diabetes. The study, published Thursday, was conducted by researchers at Oxford University and analyzed the records of more than 100,000 U.S. patients, including 20,000 who were taking semaglutide, commonly known as Ozempic or Wegobee. The researchers…
|